Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 4, 2010, Pages 291-306

  Lin, Jiun Lih ^a,b   Thomas, Paul S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Antioxidant capacity; COPD; Exhaled breath condensate; Inflammation; Oxidants; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; CYTOKINE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE; MALONALDEHYDE; NITRIC OXIDE; PEROXIREDOXIN; PHOSPHODIESTERASE IV INHIBITOR; REACTIVE NITROGEN SPECIES; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; VOLATILE ORGANIC COMPOUND;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; MUCUS GLAND; OXIDATIVE STRESS; PATHOGENESIS; PH; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; HISTONE ACETYLTRANSFERASES; HUMANS; INFLAMMATION; LUNG; MUCUS; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; TRANSCRIPTION, GENETIC;

EID: 77955195179     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2010.496818     Document Type: Review

References (161)

1. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis or urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971; 68:2374-2376.
2. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4:1241-1243.
3. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8:183-192.
4. Joppa P, Petrasova D, Stancak B, Dorkova Z, Tkacova R. Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 2007; 119:428-434.
5. Daga MK, Chhabra R, Sharma B, Mishra TK. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci 2003; 28:7-11.
6. Gessner C, Scheibe R, Wotzel M, Hammerschmidt S, Kuhn H, Engelmann L, Hoheisel G, Gillisen A, Sack Ulrich, Wirtz H. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 2005; 99:1229-1240.
7. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005; 60:293-300.
8. Behrendt CE. Mild and moderate-to-severe COPD in nonsmok- ers: distinct demographic profiles. Chest 2005; 128:1239-1244.
9. Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, Wardlaw AJ, Pavord ID. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med 2002; 166(8):1078-1083.
10. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374(9691):733-743.
11. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30(11):1191-1212.
12. Halliwell, Barry B, Poulsen, Henrik E. Cigarette smoke and oxidative stress. Berlin: Springer, 2006.
13. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128(5):833-838.
14. van Der Toorn M, Smit-de Vries MP, Slebos DJ, de Bruin HG, Abello N, van Oosterhout AJ, Bischoff R, Kauffman HF. Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 293(5):L1156-L1162.
15. Foronjy R, Alison W, D'Aarmiento J. The pharmokinetic limitations of antioxidant treatment of COPD. Pulm Pharmacol Ther 2008; 21(2):370-379.
16. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121(5 suppl):151S-155S.
17. Barnes PJ. Alveolar macrophages as orchestrator of COPD. J COPD 2004; 1(1):59-70.
18. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55:114-120.
19. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:369-373.
20. Tomita K, Barnes PJ, Adcock IM. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 2003; 301(2):572-577.
21. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343(4):269-280.
22. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung disease. J Biochem Mol Biol 2003; 36(1):95-109.
23. Rajendrasozhan S, Yao H, Rahman I. Current perspective on role of chromatin modifications and deacetylases in lung inflammation in COPD. J COPD 2009; 6(4):291-297.
24. Feldman C, Anderson R, Kanthakumar K, Vargas A, Coles PJ, Wilson R. Oxidant-mediated ciliary dystrunction in human respiratory epithelium. Free Radic Biol Med 1994; 17(1):1-10.
25. Wright DT, Fischer BM, Li C, Rochelle LG, Akley NJ, Adler KB. Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism. Am J Physiol 1996; 271(5 pt 1):L854-L861.
26. Kim YD, Jeon JY, Woo HJ, Lee JC, Chung JH, Song SY, Yoon SK, BaekSH. Interleukin-1β induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PL3K in human airway epithelial cells. J Korean Med Sci 2002; 17:765-771.
27. Levine SJ, Larivee P, Logun C, Angus CW, Ognibene FP, Shelhamer JH. Tumor necrosis factor-α induces mucin hyuper- secretion and MUC2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 1995; 12:196-204.
28. Yoon JH, Kim KS, Kim HU, Linton JA, Lee JG. Effects of TNF-α and IL-1β on mucin, lysozyme, IL-6 and IL-8 in passage- 2 normal human nasal epithelial cells. Acta Otolaryngol 1999; 119:905-910.
29. Li JD, Dohrman AF, Gallup M, Miyata S, Gum JR, Kim YS, Nadel JA, Prince A, Basbaum CB. Transcriptional activation of mucin by pseudomonas aeruginosa lipopolysacchirde in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci USA 1997; 94:967-972.
30. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7:53-62.
31. Anwar S, Whyte MKB. Implications of apoptotic cell death of es- identand recruited cells in COPD. J COPD 2008; 5(3):143-145.
32. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117:684-694.
33. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Res J 2005; 25:250-258.
34. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125:626-632.
35. Hodge S, Hodge G, Holmes M, Reynolds PN. Apoptosis in COPD. Cur Resp Med Rev 2005; 1:33-41.
36. Park JW, Ryter SW, Choi AMK. Functional significance of apoptosis in chronic obstructive pulmonary disease. J COPD 2007; 4(4):347-353.
37. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Care Med 2003; 167(3):418-424.
38. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158(4):1277-1285.
39. Bowler RP, Nicks M, Tran K, Tanner G, Cang LY, Young SK, Worthen GS. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. Amer J Respir Cell Mol Biol 2004; 31:432-439.
40. Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, peroxynitrite. Annals NY Aca Sci 1993; 686:12-27.
41. Fireman E, Shtark M, Priel IE, Shiner R, Mor R, Kivity S, Fireman Z. Hydrogen peroxide in exhaled breath condensate (EBC) vs eosinophil count in induced sputum (IS) in parenchymal vs airways lung disease. Inflammation 2007; 30:44-51.
42. Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009; 4(2):172-178.
43. Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Hom S, Gaston B, Hunt J. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Res J 2003; 22:889-894.
44. Mulkey DK, Henderson RA, Ritucci NA, Putnam RW, Dean JB. Oxidative stress decreases pHi and Na+/H+ exchange and increases excitability of solitary complex neurons from rat brain slices. Am J Physiol Cell Physiol 2004; 286:C940-C951.
45. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway disease. Am J Respir Crit Care Med 2002; 165:1364-1370.
46. Pradico D, Lawson JA, Rokach J, FitzGerald GA. The iso- prostanes in biology and medicine. Trends Endocrinol Metab 2001; 12:243-247.
47. Makris D, Paraskakis E, Korakas P, Karagiannakis E, Sourvinos G, Siafakas NM, Tzanakis N. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 2008; 72(2):138-144.
48. Isik B, Isk SR, Yolacan H, Isik MR. Serum malonyldialdehyde and paraoxonase level in chronic obstructive pulmonary disease. Turk Res J 2005; 6:1.
49. Calikoglu M, Unlu A, Tamer L, Ercan B, Bugdayci R, Atik U. The levels of serum vitamin C, malonyldialdehyde and erythro- cyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med 2002; 40:10.
50. Balint B, Donnelly E, Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 2001; 56:456-461.
51. Kharitonov SA, Barnes PJ. Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 2003; 3:121-129.
52. Osoata G, Hanazawa T, Brindicci C, Ito M, Barnes PJ, Kharitonov S, Ito K. Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine. Chest 2009; 135:1513-1520.
53. Montuschi P, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001; 120(2):496-501.
54. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitono SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005; 26:52-59.
55. Ansarin K, Chatkin JM, Ferreira IM, Gutierrez CA, Zamel N, Chapman KR. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J 2001; 17:934-938.
56. Ji Y, Neverova I, Van Eyk JE, Bennett BM. Nitration of tyro- sine 92 mediates the activation of rat microsomal glutathione S- transferase by peroxynitrite. J Biol Chem 2006; 281:1986-1991.
57. Balint B, Kharitonov SA, Hanazawa T, Donnelly LE, Shah PL, Hodson ME, Barnes PJ. Increased introtyrosine in exhaled breath condensate in cystic fibrosis. Eur Res J 2001; 17:1201-1207.
58. Ueshima K, Minakata Y, Sugiura H, Yanagisawa S, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamagata T, Ichinose M. The influence of free 3-nitrotyrosine and saliva on the quantitative analysis of protein-bound 3-nitrotyrosine in sputum. Anal Chem Insights 2007; 2:1-7.
59. Ricciardolo FL, Caramori G, Ito K, Capelli A, Brun P, Abatangelo G, Papi A, Chung KF, Adcock I, Barnes PJ, Donner CF, Rossi A, Di Stefano A. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol 2005; 116(5):1028-1035. (Pubitemid 41571783)
60. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997; 8:1-7.
61. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Garmiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Res J 2003; 21:589-593.
62. Montuschi P, Kharitonov S, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58(7):585-588.
63. Scheideler L, Manke HG, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath: a possible diagonstic tool? Am Rev Respir Dis 1993; 148:778-784.
64. Cunningham S, McColm JR, Ho LP, Greening AP, Marshall TG. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Res J 2000; 15:955-957.
65. Cao WQ, Duan YX. Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 2006; 52(5):800-811.
66. Rovina N, Papapetropoulos A, Kollintza A, Michailidou M, Simoes D, Roussos C, Gratziou C. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chornic obstructive pulmonary disease. Respir Res 2007; 8:53-60.
67. Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125(1):22-25.
68. Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2007; 63:493-499.
69. Moore B, Murphy RF, Agrawal DK. Interaction of TGF-beta with immune cells in airways disease. Curr Mol Med 2008; 8(5):427-436.
70. Duvernelle C, Freund V, Frossard N. Transforming growth factor-beta and its role in asthma. Pulm Pharmacol Ther 2003; 16(4):181-196.
71. Van Berkel JJBN, Dallinga JW, Moller GM, Godschalk RWL, Moonen EJ, Wouters EFM, Van Schooten FJ. A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med 2009; 104(4):557-563.
72. Ibrahim B, Basanta M, Dockry R, Tal-Singer R, Douce D, Woodcock AA, Singh D, Fowler SJ. Exhaled volatile organic compounds as potential biomarkers in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2010; 181:A1012.
73. Kanazawa H, Yoshikawa J. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD. Chest 2005; 128:3191-3197.
74. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163:737-744.
75. Sakao S, Tatsumi K, Hashimoto T, Igari H, Shino Y, Shirasawa H, Kuriyama T. Vascular endothelial growth actor and the risk of smoking-related COPD. Chest 2003; 124:323-327.
76. Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 2008; 10(2):355-370.
77. MacNee W. Treatment of stable COPD: antioxidants. Eur Respir Rev 2005; 14:12-22.
78. Oberley-Deegan RE, Regan EA, Kinnula VL, Crapo JD. Extracellular superoxide dismutase and risk of COPD. J COPD 2009; 6(4):307-312.
79. Larsen GL, White CW, Takeda K, Loader JE, Nguyen DD, Joetham A, Groner Y, Gelfand EW. Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am J Physiol Lung Cell Mol Physiol 2000; 279(2):L350-L359.
80. White CW, Avraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991; 87(6):2162-2168.
81. Chang LY, Kang BH, Slot JW, Vincent R, Crapo JD. Immuno- cytochemical localization of the sites of superoxide dismutase induction by hyperoxia in rat lungs. Lab Invest 1995; 73(1):29-39.
82. Wispe JR, Warner BB, Clark JC, Dey CR, Neuman J, Glasser SW, Crapo JD, Chang LY, Whitsett JA. Human Mn- superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992; 267(33):22937-22941.
83. Harju T, Kaarteenaho-Wiik R, Sirvio R, Paakko P, Crapo JD, Oury TD, Shoini Y, Kinnula VL. Manganese superoxide dismutase is increased in the airways of smokers lungs. Eur Res J 2004; 24:765-771.
84. Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immuno- cytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest J Tech Meth Pathol 1994; 70:889-898.
85. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 1996; 20:957-965.
86. Gao F, Kinnula VL, Myllarniemi M, Oury TD. Extracellular su- peroxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 2008; 10:343-354.
87. Reinhard C, Meyer B, Fuchs H, Stoeger T, Eder G, Ruschen- dorf F, Heyder J, Nurnberg P, De Angelis MH, Schulz H. Genomewide linkage analysis identifies novel genetic loci for lung function in mice. Am J Respir Crit Care Med 2005; 171:880-888.
88. Ganguly K, Stoeger T, Wesselkamper SC, Reinhard C, Sartor MA, Medvedovic M, Tomlinson CR, Bolle I, Mason JM, Leikauf GD, Schulz H. Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure. Physiol Genom 2007; 31:410-421.
89. Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O'Connor GT. Framingham Heart Study genome-wide associations: results for pulmonary function measures. BMC Med Genetics 2007; 8(Supp 1):S8.
90. Young RP, Hopkins R, Black PN, Eddy C, Wu L, Gamble GD, Mills GD, Garret JE, Eaton TE, Rees MI. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006; 61:394-399.
91. Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordest- gaard BG. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:858-864.
92. Harju T, Mazur W, Merikallio H, Soini Y, Kinnula VL. Glutathione-S- transferases in lung and sputum specimens, effects of smoking and COPD serverity. Respiratory Research 2008, 9:80, doi:10.1186/1465-9921-9-80.
93. Joshi UM, Kodavanti PR, Mehendale HM. Glutathione metabolism and utilization of external thiols by cigarette smoke- challenge, isolated rat and rabbit lungs. Toxicol Appl Pharmacol 1988; 96:324-335.
94. Park EM, Park YM, Gwak YS. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic Biol Med 1998; 25:79-86.
95. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152-157.
96. Wang Y, Feinstein SI, Fisher AB. Peroxiredoxin 6 as an an- tioxidant enzyme protection of lung alveolar epithelial type II cells from HO-induced oxidative stress. J Cell Biochem 2008; 104:1274-1285.
97. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1 -cys peroxiredoxin causes lipid perox- idation and apoptosis in lung epithelial cells. J Biol Chem 2002; 277:47729-49934.
98. Wang Y, Manevich Y, Feinstein SI, Fisher AB. Adenovirus- mediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1188-L1193.
99. Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am J Respir Cell Mol Biol 2006; 34:481-486.
100. Rizvi SI, Maurya PK. Alterations in antioidant enzymes during aging in humans. Mol Biotechnol 2007; 37(1):58-61.
101. Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S. Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. J Lipid Res 2009; 50:59-70.
102. Inomata T, Betsuyaku T, Ito Y, Nasuhara Y, Nishimura M. Catalse expression in pulmonary macrophages of smokers and chronic obstructive pulmonary disease (COPD) patients. Amer J Respir Crit Care Med 2009; 179:A4157.
103. Mak JCW, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, Lam WK, Chan-Yeung M. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J 2007; 30:684-690. (Pubitemid 351194828)
104. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043-1046.
105. Shinohara T, Kaneko T, Nagashima Y, Ueda A, Tagawa A, Ishigatsubo Y. Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cNDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. Hum Gene Ther 2005; 16:318-327.
106. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 2007; 36:158-165.
107. Choi BM, Pae HO, Jeong YR, Oh GS, Jun CD, Kim BR, Kim YM, Chung HT. Overexpression of heme oxygenase (HO)-1 renders Jurkat T cells resistant to fas-mediated apoptosis: involvement of iron released by HO-1. Free Radic Biol Med 2004; 36:858-871.
108. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM. Carbon monoxidemodulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 2002; 27:739-745.
109. Guenegou A, Leynaert B, Pin I, Le Moel G, Zureik M, Neukirch F. Serum carotenoids, vitamins A and E, 8 year lung function decline in a general population. Thorax 2006; 61(4):320-326.
110. Wu TC, Huang YC, Hsu SY, Wang YC, Yeh SL. Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease. Int J Vitam Nutr Res 2007; 77(4):272-279.
111. Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997; 38:205-227.
112. Stav D, Raz M. Effect of N-acetylcysteine on airtrapping in COPD: a randomized placebo-controlled study. Chest 2009; 136(2):381-386.
113. Committee BTSR. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 1985; 40(11):832-835.
114. Grassi C, Morandini GC. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis. Eur J Clin Pharmacol 1976; 9(5-6):393-396.
115. Hansen NC, Skriver A, Brorsen-Riis L, Balslov S, Evald T, Maltbaek N, Gunnersen G, Garsdal P, Sander P, Pedersen JZ, Ibsen TB, Rasmussen FV. Orally administered N-acetylcysteine may improve general well-being in patietns with mild chronic bronchitis. Respir Med 1994; 88(7):531-535.
116. Schermer T, Chavannes N, Dekhuijzen R, Wouters E, Muris J, Akkermans R, van Schayck O, van Weel C. Fluticasone and N-acetylcysteine in primary care patietns with COPD or chronic bronchitis. Respir Med 2009; 103(4):542-551.
117. Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troost- ers T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randmoized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005; 365:1552-1560. (Pubitemid 40615404)
118. Schwartz J, Weiss ST. Dietary factors and their relation to respiratory symptoms. The second National Health and Nutrition Examination Survey. Am J Epidemiol 1990; 132:67-76.
119. Schwartz J, Weiss ST. Relationship between dietary vitamin C intake and pulmonary function in the first national health and nutrition examination survey (NHANES I). Am J Clin Nutr 1994; 59:110-114. (Pubitemid 24021718)
120. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000; 151:975-981.
121. Tabak C, Feskens EJ, Heederik D, Kromhout D, Menotti A, Blackburn HW. Fruit and fish consumption: a possible explanation for population differences in COPD mortality (The Seven Countries Study). Eur J Clin Nutr 1998; 52:819-825.
122. Tabak C, Smit HA, Heederik D, Ocke MC, Kromhout D. Diet and chronic obstructive pulmonary disease: inderdependent ben eficial effects of fruits, whole grains and alcohol (the MORGAN Study). Clin Exp Allergy 2001; 31:747-755.
123. Miedema I, Feskens EJ, Heederik D, Kromhout D. Dietary determinants of long-term incidence of chronic non-specific lung disease: The Zutphen Study. Am J Epidemiol 1993; 138:37-45.
124. Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathology 1998; 152:269-278.
125. Tager M, Piecyk A, Kohnlein T, Thiel U, Ansorge S, Welte T. Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers: chronic obstructive pulmonary disease. Free Radic Biol Med 2000; 29(11):1160-1165.
126. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 1996; 154(4 pt 1):1055-1060.
127. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29:1224-1238.
128. Varkey JB, Varkey B. Viral infections in patients with chronic ob- strutive pulmonary disease. CurrOpin Pulm Med 2008; 14:89-94.
129. Novel Swine-Origin Influenza A (H1N1) Virus Investiation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
130. Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet 2009; 374:744-755.
131. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax 2003; 58(4):294-298.
132. Drost EM, Ritchie HE, Skwarska E. NF-κB activation in airway leucocytes in COPD patients. Eur Res J 2001; 160:260s.
133. Nishikawa M, Kakemizu N, Ito T, Kudo M, Kaneko T, Suzuki M, Udaka N, Ikeda H, Okubo T. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999; 20:189-198.
134. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasa- hara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29:88-97.
135. Hirayama F, Lee AH, Binns CW, Zhao Y, Hiramatsu T, Tanikawa Y, Nishimura K, Taniguchi H. Do vegetables and fruits reduce the risk of chronic obstructive pulmonary disease? A case-control study in Japan. Prev Med 2009; 49(2-3):184-189.
136. Sutherland ER, Crapo JD, Bowler RP. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. J COPD 2006; 3(4):195-202.
137. Zuin R, Palamidese A, Negrin R, Catozzo L, Scarda A, Balbinot M. High-dose N-acetylcysteine in patietns with exacerbations of chronic obstructive pulmonary disease. Clin Drug Investig 2005; 25(6):401-408.
138. Epperly MW, Defilippi S, Sikora C, Gretton J, Kalend A, Greenberger JS. Intractracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Therapy 2000; 7:1011-1018.
139. Griese M, Ramakers J, Krasselt A, Starosta V, Van Konings- bruggen S, Fischer R, Ratjen F, Miillinger B, Huber RM, Maier K, Rietschel E, Scheuch G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004; 169:822-828.
140. Bishop C, Hudson VM, Hilton SC, Wild C. A pilot study of the effect of inhaled buffered glutathione on the clinical status of patients with cystic fibrosis. Chest 2005; 127:308-317.
141. MacNee W, Rahman I. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 1995; 50(Supp 1):S53-S58.
142. Borok Z, Buhl R, Grimes GJ, Bokser AD, Hubbard RC, Holroyd KJ, Roum JH, Czerski DB, Cantin AM, Crystal RG. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338(8761):215-216.
143. Gillissen A, Jaworska M, Orth M, Coffiner M, Maes P, App EM, Cantin AM, Schultze-Werninghaus G. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir Med 1997;91:159-168.
144. Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase- 1 in patients with emphysema. Chest 2003; 125(4):1724-1732.
145. Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bre- denbroeker D, Fabbri LM. Effect of 1 -year treatment with rof- lumilast in severe chronic obstructive pulmonary disease. Am J Respir Care Med 2007; 176(2):154-161.
146. Vestbo J, Tan L, Atkinson G, Ward J. and on behalf of the UK-500,001 Global Study Team. A controlled trial of 6-weeks' treatment with a novel inhaled phophodiesterase type-4 inhibitor in COPD. Eur Respir J 2009; 33(5):1039-1044.
147. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164:731-737.
148. Montuschi P. Review: analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Res Dis 2007; 1:5-23.
149. Liu J, Thomas PS. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Med Sci Monit 2005; 11(8):MT53-MT62.
150. Kharitonov SA, Barnes PJ. Exhaled Biomarkers. Chest 2006; 131:1541-1546.
151. Liu J, Conrad DH, Chow S, Tran VH, Yates DH, Thomas PS. Collection devices influence the constituents of exhaled breath condensate. Eur Respir J 2007; 30:807-808.
152. Silkoff PE, Erzurum SC, Lundberg JO, George SC, Marczin N, Hunt JF, Effros R, Horvath I. ATS Workshop Proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006; 3(2):131-145.
153. Chow S, Yates DH, Thomas PS. Reproducibility of exhaled breath condensate markers. Eur Respir J 2008; 32(4):1124-1126.
154. Lee W, Thomas PS. Oxidative stress in COPD and its measurement through exhaled breath condensate. Clin Transl Sci 2009; 2(2):150-155.
155. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large population. Amer J Respir Crit Care Med 2008; 178(9):906-912.
156. Arcaroli JJ, Hokanson JE, Abraham E, Geraci M, Murphy JR, Bowler RP, Dinarello CA, Silveira L, Sankoff J, Heyland D, Wischmeyer P, Crapo JD. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. AmerJ Respir Crit Care Med 2009; 179:105-112.
157. Sagiura H, Ichikawa T, Liu X, Kobayashi T, Wang XQ, Kawasaki S, Togo S, Kamio K, Mao L, Ann Y, Ichinose M, Rennard SI. N-acetyl-l-cysteine inhibits TGF-beta(1)-induced profibrotic response in fibroblasts. Pulm Pharmacol Ther 2009; 22(6):487-491.
158. Decramer M, Dekhuijzen PNR, Troosters T, Van Herwaar- den C, Rutten-Van Molken M, Van Schayck CPO, Olivieri D, Lankhorst I, Ardia A. The Bronchitis Randomized on NAC Cost-Utility Study (BRONCUS): hypothesis and design. Eur Res J 2001; 17:329-336.
159. Kirkil G, Hamdi Muz M, Seckin D, Sahin K, Kucuk O. Antiox- idant effect of zinc picolinate in patietns with chronic obstructive pulmonary disease. Respir Med 2008; 102(6):840-844.
160. Nadeem A, Raj HG, Chhabra SK. Effect of vitamin E supplementation with standard treatment on oxidant-antioxidant status in chronic obstructive pulmonary disease. Indian J Med Res 2008; 128(6):705-711.
161. Conklin JD, Trinity JD, Amann M, Fjeldstad A, Wray DW, Richardson RS. Antioxidant supplementation improves oxygen delivery and blood flow to exercising skeletal muscle in COPD. AmerJ Respir Crit Care Med 2010; 181:A6842.